Skip to main navigation
Skip to search
Skip to main content
University of Birmingham Home
Help & FAQ
Home
Research output
Profiles
Research units
Projects
Activities
Datasets
Equipment
Prizes
Press/Media
Search by expertise, name or affiliation
Antiplatelet agents and anticoagulants for hypertension
Gregory Lip
, DC Felmeden, Girish Dwivedi
Sport, Exercise and Rehabilitation Sciences
Cardiovascular Sciences
Birmingham Medical School
Research output
:
Contribution to journal
›
Review article
22
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Antiplatelet agents and anticoagulants for hypertension'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Hypertension
100%
Elevated Blood Pressure
100%
Anticoagulants
100%
Antiplatelet Agents
100%
Placebo
66%
Acetylsalicylic Acid
66%
Active Treatment
50%
Meta-analysis
33%
Diastolic Blood Pressure
33%
Systolic Blood Pressure
33%
Myocardial Infarction
33%
Thrombosis
33%
Antithrombotic Therapy
33%
Antiplatelet Therapy
33%
Total Mortality
33%
Cardiovascular Disease
16%
No Significant Difference
16%
Inclusion Criteria
16%
All-cause Mortality
16%
Coronary Artery Disease
16%
MEDLINE
16%
Embase
16%
Heart Failure
16%
Primary Prevention
16%
High Blood Pressure
16%
Anticoagulation
16%
Cardiovascular Mortality
16%
Atrial Fibrillation
16%
Thromboembolism
16%
Peripheral Vascular Disease
16%
Ischemic Stroke
16%
Associated Complications
16%
Secondary Prevention
16%
Warfarin
16%
Cardiovascular Events
16%
Coronary Events
16%
Large Trials
16%
Oral Anticoagulants
16%
Electronic Search
16%
Composite Endpoint
16%
Stroke Event
16%
Vascular Events
16%
Clopidogrel
16%
Absolute Reductions
16%
Systemic Blood Pressure
16%
Thrombotic Events
16%
Small Clinical Trials
16%
Vascular Death
16%
Major Haemorrhage
16%
Intravascular Pressure
16%
Central Hypertension
16%
Medicine and Dentistry
Elevated Blood Pressure
100%
Anticoagulant
100%
Antiplatelet Drug
100%
Placebo
66%
Apoplexy
66%
Acetylsalicylic Acid
66%
Cardiovascular System
33%
Meta-Analysis
33%
Blood Pressure
33%
Diastolic Blood Pressure
33%
Systolic Blood Pressure
33%
Myocardial Infarction
33%
Thrombosis
33%
Bleeding
33%
Antithrombotic Therapy
33%
Thromboembolism
33%
Antiplatelet
33%
Systematic Review
16%
Cardiovascular Disease
16%
Ischemic Heart Disease
16%
Randomized Controlled Trial
16%
Congestive Heart Failure
16%
All Cause Mortality
16%
Anticoagulation
16%
Cardiovascular Mortality
16%
Atrial Fibrillation
16%
Primary Prevention
16%
Brain Ischemia
16%
Secondary Prevention
16%
Peripheral Vascular Disease
16%
Warfarin
16%
Antithrombotic
16%
Clopidogrel
16%
Nursing and Health Professions
Anticoagulant Agent
100%
Antithrombocytic Agent
100%
Elevated Blood Pressure
100%
Cerebrovascular Accident
66%
Alka-Seltzer
66%
Placebo
66%
Blood Pressure
33%
Meta Analysis
33%
Diastolic Blood Pressure
33%
Heart Infarction
33%
Systolic Blood Pressure
33%
Bleeding
33%
Thromboembolism
33%
Thrombosis
33%
Systematic Review
16%
Cardiovascular Disease
16%
Ischemic Heart Disease
16%
Primary Prevention
16%
Congestive Heart Failure
16%
All Cause Mortality
16%
Cardiovascular Mortality
16%
Anticoagulation
16%
Medline
16%
Warfarin
16%
Secondary Prevention
16%
Embase
16%
Atrial Fibrillation
16%
Brain Ischemia
16%
Clopidogrel
16%
Peripheral Vascular Disease
16%
Pharmacology, Toxicology and Pharmaceutical Science
Anticoagulant Agent
100%
Antithrombocytic Agent
100%
Elevated Blood Pressure
100%
Placebo
66%
Cerebrovascular Accident
66%
Acetylsalicylic Acid
66%
Heart Infarction
33%
Bleeding
33%
Thrombosis
33%
Thromboembolism
33%
Antithrombotic Therapy
33%
Antiplatelet
33%
Randomized Controlled Trial
16%
All Cause Mortality
16%
Congestive Heart Failure
16%
Ischemic Heart Disease
16%
Cardiovascular Disease
16%
Brain Ischemia
16%
Cardiovascular Mortality
16%
Atrial Fibrillation
16%
Peripheral Vascular Disease
16%
Warfarin
16%
Clopidogrel
16%
Neuroscience
Placebo
100%
Cerebrovascular Accident
100%
Antiplatelet Drug
100%
Hypertension
100%
Antithrombotic
75%
Meta-Analysis
50%
Myocardial Infarction
50%
Ischemic Heart Disease
25%
Brain Ischemia
25%
Vascular Disease
25%
Atrial Fibrillation
25%
Warfarin
25%
Clopidogrel
25%